Godrej Consumer Products Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/7owu0m4o2l03pylhr4ncejr4.pdf

Key Takeaways


Household Insecticide: The Core Problem

Sitapati: "Our challenge in Household Insecticide, Abneesh is not to win share, our primary challenge given the fact that we are market leader is to premiumize this category and grow it faster."

The Advertising Bet: Philosophy Over Quarters

Sitapati: "This is certainly not something we are going to do for a few quarters, it's certainly more philosophical, in terms of what our portfolio deserves, and what we should do for it."

Soaps: The Volume Recovery Thesis

Sitapati: "When prices went up, we did not pass on the full inflation to consumers because we knew that prices would come down. When prices came down... we passed it on quickly because our underlying principle on this is to be on the side of consumers."

International: Indonesia Bleeds, Africa Invests

MarketTrendCommentary
Indonesia▼ Sharp declineSales –8%, gross margins –14%, EBITDA –41%. Ex-Saniter growth was 12%, so the base effect from Saniter inventory reduction is the dominant drag. High-cost inventory consumption and scale deleverage added to the margin hit.
GUAM▬ InvestingGood operating quarter with 15% growth, but EBITDA fell 12% on a 77% ATL increase. Margins down ~270 bps: half from media, half from input costs and sharp currency depreciation in some markets.
Africa▬ Mixed15% sales growth, 8% gross margin expansion, but EBITDA declined 12% as ATL rose 77%. Severe currency depreciation pushed up forex and interest costs.
Sitapati: "I hope that Q3 will come to near flat in Indonesia and Q4 onward, we should see very high growth."

Portfolio Bright Spots


Margins: The Walk and the Philosophy

Sitapati: "I don't think we should stop at either cut on media, because we are not achieving a target EBITDA margin or stop at an EBITDA margin, even if there are more cost to be saved."

Guidance & Commitments

CommitmentSpecificsTimeline
FY23 sales growthDouble-digit sales growthFY23 full year
FY23 volume growthLow single-digit volume growthFY23 full year
Indonesia growth trajectoryNear-flat in Q3, very high growth from Q4 onwardQ3 FY23 / Q4 FY23
Indonesia marginsAmbition to reach early-20s margins while continuing marketing investmentsNo date (investment mode continues)
Africa marginsReach high-teens margin via scale, cost savings, operating model changesNo date (target "very much intact")
Household Insecticide volumesReturn to normative level in H2 on softer comparators and seasonality shiftH2 FY23
Soap volumesCompensatory upside expected "pretty soon" to compensate for fallen volumesNear-term (no specific quarter)
Soap gross marginsReturn close to FY21 normative levelsNo date
Overall gross marginsRise sequentially and YoY in coming quartersComing quarters
Advertising spendIncrease from current levels over next four to five years4–5 year horizon
EBITDA marginNo massive declines versus the past; media increase offset by cost savings and volume leverageOngoing

Key Metrics

MetricQ2 FY23
Sales growth7%, three-year CAGR of 9%
Volume growth-5%, three-year CAGR of +1%
Gross margin growth+3%, after four quarters of decline
Advertising spend growth~50% increase
EBITDA growth-15%
PAT growth-25%, led by VAT Amnesty Scheme settlement and currency volatility
Operating cash flowDoubled, driven by working capital simplification
India sales growth8%, three-year CAGR of 1% vs 4% in Q1
India gross margin growth7%
India ATL growth52%
India EBITDA growth-5%
GUAM sales growth15%
GUAM gross margin growth8%
GUAM ATL growth77%
GUAM EBITDA growth-12%
Indonesia sales growth-8%, ex-Saniter growth of 12%
Indonesia gross margin growth-14%
Indonesia EBITDA growth-41%
Indonesia margin decline930 bps, 150 bps from upfront working media investment
Africa margin decline~270 bps, half from upfront media investments, half from input cost and currency depreciation
ATL growth46%
Working media growth70%
India SKU reduction25% in the last six months
GUAM SKU reductionOne-third in the last one year
Inventory days51 days as at September '22, down from 60 days as at September '21
Cost-to-serve reduction30 bps in Q2 FY22, despite high inflation
Soaps long-term volume CAGR3% to 3.5% for the category, GCPL expected at 4% to 4.5%
Soaps market share gain trajectory50 to 60 bps per year for the last decade
Margin expansion target150 to 200 bps over a period of time